- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.2: 4 residues within 4Å:- Chain A: G.54, N.55, E.87
- Ligands: NAG-NAG-BMA.1
No protein-ligand interaction detected (PLIP)NAG-NAG.4: 4 residues within 4Å:- Chain C: G.54, N.55, E.87
- Ligands: NAG-NAG-BMA.3
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 4 residues within 4Å:- Chain E: G.54, N.55, E.87
- Ligands: NAG-NAG-BMA.5
No protein-ligand interaction detected (PLIP)- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.7: 4 residues within 4Å:- Chain A: S.123, W.124, P.125, N.126
Ligand excluded by PLIPNAG.8: 3 residues within 4Å:- Chain A: P.159, N.160, Y.198
Ligand excluded by PLIPNAG.9: 1 residues within 4Å:- Chain A: N.12
Ligand excluded by PLIPNAG.10: 2 residues within 4Å:- Chain A: T.16, N.24
Ligand excluded by PLIPNAG.11: 3 residues within 4Å:- Chain A: N.287, S.289, L.290
Ligand excluded by PLIPNAG.12: 5 residues within 4Å:- Chain B: E.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.13: 4 residues within 4Å:- Chain C: S.123, W.124, P.125, N.126
Ligand excluded by PLIPNAG.14: 3 residues within 4Å:- Chain C: P.159, N.160, Y.198
Ligand excluded by PLIPNAG.15: 1 residues within 4Å:- Chain C: N.12
Ligand excluded by PLIPNAG.16: 2 residues within 4Å:- Chain C: T.16, N.24
Ligand excluded by PLIPNAG.17: 3 residues within 4Å:- Chain C: N.287, S.289, L.290
Ligand excluded by PLIPNAG.18: 5 residues within 4Å:- Chain D: E.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIPNAG.19: 4 residues within 4Å:- Chain E: S.123, W.124, P.125, N.126
Ligand excluded by PLIPNAG.20: 3 residues within 4Å:- Chain E: P.159, N.160, Y.198
Ligand excluded by PLIPNAG.21: 1 residues within 4Å:- Chain E: N.12
Ligand excluded by PLIPNAG.22: 2 residues within 4Å:- Chain E: T.16, N.24
Ligand excluded by PLIPNAG.23: 3 residues within 4Å:- Chain E: N.287, S.289, L.290
Ligand excluded by PLIPNAG.24: 5 residues within 4Å:- Chain F: E.147, E.150, S.151, N.154, T.156
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Y. et al., CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface. J. Mol. Biol. (2017)
- Release Date
- 2017-05-31
- Peptides
- Hemagglutinin HA1: ACE
Hemagglutinin HA2: BDF
scFv: GHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
GH
HI
I
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-mer
- Ligands
- 3 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Liu, Y. et al., CryoEM Structure of an Influenza Virus Receptor-Binding Site Antibody-Antigen Interface. J. Mol. Biol. (2017)
- Release Date
- 2017-05-31
- Peptides
- Hemagglutinin HA1: ACE
Hemagglutinin HA2: BDF
scFv: GHI - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
GH
HI
I